Due to its critical role in NK cell differentiation and CD8 + T cell homeostasis, the importance of IL-15 is more firmly established for cytolytic effectors of the immune system than for CD4 + T cells. The increased levels of IL-15 found in several CD4
Introduction
The pro-inflammatory cytokine IL-15 is produced predominantly by activated monocytes/macrophages [1] , but can also be produced by T cells [2] and in mucosal tissues by epithelial cells [3] [4] [5] . Expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide [6] , IL-is involved in several types of infections [7] . Bacterial infection with Salmonella or Mycobacterium [8, 9] , or viral infection with Influenza has been shown to induce the expression of IL-15 [10, 11] . IL-15 is also implicated in several inflammatory disorders and autoimmune diseases [1, [12] [13] [14] . IL-15 is present at high concentrations in rheumatoid arthritis synovial fluid [15, 16] and elevated in the serum of patients with systemic lupus erythematosus [17] or type 1 diabetes [18] . Additionally, IL-15 is heightened in the affected tissues in autoimmune thyroid disease [19] and celiac disease [20] .
IL-15 given exogenously can enhance immune responses and these properties are exploited in tumor therapy [21, 22] and in vaccination strategies [23] [24] [25] [26] [27] . IL-15 helps the development and activity of NK cells [28] , CD4 + T cells [29, 30] and CD8 + T cells [31] [32] [33] . For instance, IL-15 prolongs the survival of effector T cells against Listeria monocytogenes and Mycobacterium bovis [10] and augments the response by respiratory CD8 + T cells in Influenza infections [11] . IL-15 also augments the generation of tetanus toxoid-specific effector CD4 + T cells in rhesus macaques [34] . Our previous studies have shown that IL-15 enhances the proliferative response of TCR-stimulated CD4 + T cells in vitro [29, 35] . IL-15 treatment is known to promote a persistent immune response through its actions on memory CD8
+ T cells [32, 36, 37] and the proliferation of human memory CD4 + T cells in vitro and mouse Ag-specific CD4
+ memory T cells in vivo [38, 39] . Initial studies suggested that IL-15 is mainly critical for CD8 + T cell homeostasis [40] [41] [42] , and less for homeostasis of naive or memory CD4 + T cells [5, [43] [44] [45] , especially because normal numbers of memoryphenotype CD4
+ T cells are present in IL-15-deficient mice [46] . Similarly, IL-15 is reported to have only a minimal role in the homeostasis of Ag-specific CD4
+ memory T cells [47] . However, recent studies have revealed that IL-15 is important for the homeostatic proliferation of both types of memory cells [48] [49] [50] . For instance, in normal nonlymphopenic hosts where IL-7 levels are low, virus Ag-specific CD4
+ memory cells are dependent on IL-15 for their basal homeostatic proliferation and long-term survival [49] . Also, the IFN-c-producing memory CD4 + T cells induced by transient bacterial infection with Listeria monocytogenes express IL-15Rb and are responsive to IL-15 [50] .
Deficient development or function of CD25 +
CD4
+ regulatory T (Treg) cells causes organ-specific autoimmune diseases in animal models, demonstrating their crucial role in maintaining selftolerance [51] [52] [53] [54] . In human peripheral blood, approximately 1.5-3.0% of total CD4 + T cells express high levels of CD25 [55] and have similar regulatory properties as murine CD25
+

CD4
+ T cells [55] [56] [57] . Potent TCR stimulation [58, 59] , but also cytokines, e.g. high dose IL-2 [60] [61] [62] or IL-6 [63] render effector T cells resistant to the suppression by Treg cells. The role of IL-15 in the homeostasis and function of Treg cells is not clear, but IL-15 can partially support Treg cell development in the absence of IL-2 [64] and protect human effector T cells against Treg cell action [65] .
In this study we examined how low doses of IL-15 influence a primary CD4
+ T cell response to low doses of TCR/CD3-triggering. The growth factor activity of IL-15 on CD4 + T cells depends on TCR-induced IL-2 production in the first phase of activation, and only later supports CD4 + T cell expansion independent of IL-2. IL-15 also promotes CD4 + T cell expansion in a more indirect way, namely by lifting the suppressive activity Foxp3 expressing CD25 High CD4 + T cells that originate from natural CD25 + CD4 + Treg cells after TCR-stimulation.
Results
IL-15 not only Exerts Growth Factor Activity on CD8
+ T Cells, but also on CD4
+ T Cells
Anti-CD3 stimulation caused a dose dependent proliferative response of C57Bl/6 splenocytes and supplementation with IL-15, even at doses as low as 1 ng/ml, markedly increased both the amplitude and the duration of the proliferative response ( Figure 1A ). This growth enhancing effect of IL-15 was not mouse strain dependent or restricted to cells from a specific secondary lymphoid compartment, as bulk lymph node cells and splenocytes from Balb/c responded similarly (data not shown).
To assess the effect of IL-15 on CD4 + and CD8 + T cells, we stimulated CFSE-labeled splenocytes with anti-CD3. Dye dilution analysis showed that both CD8 + and CD4 + T cells proliferate, but that CD8 + T cells proliferated faster than CD4 + T cells, as evidenced by the higher number of generations distinguished 2 days and especially 3 days after stimulation ( Figure 1B ). CD8 + T cells were also more sensitive to stimulation, as they proliferated in response to lower anti-CD3 concentrations (data not shown). Consequently, the CD8 + T cell subset dominated the splenocyte cultures after 3 days of activation ( Figure 1B) . Nonetheless, absolute CD4 + T cell numbers did increase in time, albeit less dramatically than CD8 + T cells. Addition of IL-15 increased both CD4 + and CD8 + T cells number ( Figure 1B ), suggesting IL-15 growth enhancing effect can target both T cell subsets.
Given the predominant outgrowth of the CD8 + subset, we next analyzed the effect of IL-15 on anti-CD3 stimulation of isolated CD4 + and CD8 + T cells. Exogenous IL-15 boosted and prolonged the proliferative response of both CD8 + T cells ( Figure 1C ,D) and CD4 + T cells (Fig. 1E,F) , an effect dependent on TCR-triggering ( Figure 1C ,E). We used irradiated T cell-depleted accessory cells (TdAC) to crosslink the anti-CD3 mAb, but IL-15 also increased proliferation and cell numbers during stimulation with platebound anti-CD3 and soluble anti-CD28, suggesting IL-15 acted directly on the T cells (data not shown). The doses of IL-15 used did not cause proliferation during stimulation with soluble anti-CD3 in the absence of TdAC or in the absence of stimulation (data not shown). Similar results were obtained using either recombinant human or murine IL-15 (data not shown). CFSE proliferation studies showed that CD4 T cells had a higher proliferation index in IL-15-supplemented cultures ( Figure 1G, H We next determined whether the IL-15 growth factor activity reflects a redundant activity with IL-2 because of shared receptor subunits or a dependence on TCR-induced endogenous IL-2. We found that depletion of IL-2 using neutralizing mAb (clone JES6-5H4: Figure 2A Figure 2C ). In contrast, IL-2 2/2 CD4 + T cells were deficient in proliferation in response to anti-CD3. Addition of low doses IL-2 increased their proliferative response, albeit to a limited extend. The lack of a full restoration may be because the added amount of IL-2 was lower than what is naturally produced [66] or because IL-2 2/2 T cells contain a larger number of effector/ memory T cells [67] , which respond differently to IL-2. IL-15 did not increase the anti-CD3-stimulated proliferation of IL-2
2/2
CD4
+ T cells at all. Since sensitivity of CD4 + T cells to the growth factor activity of IL-15 depends on TCR-signals, we tested whether also the IL-2 dependence of the IL-15 growth factor activity changes as CD4 + T cells become activated. To address this, we simultaneously added IL-15 and depleted IL-2 after 1, 2, or 3 days of TCR-stimulation. This showed that the addition of IL-15 increases CD4 + T cell proliferation irrespective of the time of addition, but addition of IL-15 at the start of activation allows IL-15 to deploy its full growth factor potential ( Figure 2D ). Importantly, IL-2 depletion progressively lost its capacity to dampen IL-15 growth factor activity. As a result, IL-15 exerted its growth promoting effect independently of IL-2 by day 3 of stimulation.
Collectively, these data indicate that IL-15 growth factor activity on CD4 + T cells depends on endogenous IL-2 at the start of activation, but not at later time points. On CD8 + T cells however, IL-2 and IL-15 exert redundant growth factor activities.
IL-15-expanded CD4 + T cells Remain Dependent on IL-15
A previous report indicated that IL-15Ra is a negative regulator of TCR-stimulated proliferation of CD4 + T cells [68] . If so, blocking IL-15 should enhance proliferation of TCR-stimulated CD4 + T cells. To test this, we added a soluble form of the IL-15Ra protein (sIL-15Ra; T1) to scavenge IL-15 [69] on day 3 of stimulation. Viable CD4 + T cell counts ( Figure 3A ) and (approximately two-fold) and maintained this expression level throughout the culture period. As a result, IL-15Rb is expressed two-fold higher on day 5 when compared with unstimulated CD4 + T cells or day 5 control-stimulated CD4 + T cell cultures ( Figure 4A ). Flow cytometry showed that expression of CD122 was increased in the entire CD4
+ T cell population, rather than reflecting the outgrowth of a specific subset (data not shown).
On the other hand, IL-15 supplementation limited the anti-CD3-induced upregulation of IL-2Ra (CD25)( Figure 4A ), an activation marker known to confer sensitivity to AICD, but also a Treg marker [51, 54] . This could reflect a decrease in surface expression of CD25 on all activated T cells or a reduction in the fraction of CD25 + Treg cells. To test this, we stimulated CFSElabeled CD4
+ T cells to monitor CD25 expression. In line with its transcript expression, CD25 membrane expression was strongly upregulated upon TCR stimulation in both control and IL-15 supplemented cultures ( Figure 4B ).Interestingly, low-dose anti-CD3 stimulation generated two CD25-positive populations, expressing either high or intermediate (Int) levels of CD25. On day two, the effect of IL-15 supplementation on CD25 at the mRNA level had not yet translated to the level of surface protein ( Figure 4B ). CFSE-dilution experiments showed that both CD25 Int and CD25
High subsets actively proliferated ( Figure 4C , left panels). The CD25
High subset constituted approximately 15% and 22% of the viable CD4
+ T cell population after four and five days, respectively. Supplementation with human IL-15 reduced the relative proportion of CD25 High cells to approximately 7% and 11% ( Figure 4C , right panels), seemingly sustaining mainly the expansion of the CD25 Int subset. A similar trend was also observed using murine IL-15 (data not shown). Exogenous IL-15 did increase the absolute numbers of CD4 + T cells expressing no or intermediate levels of CD25, but not those with high levels of CD25, both on day four and five ( Figure 4D ). This indicates that the drop in the CD25 High CD4 + T cells is relative and results from a greater expansion of cells expressing no or intermediate levels of CD25. The cells that had undergone most divisions upon stimulation with anti-CD3 in the absence of IL-15 expressed mostly high levels of CD25 ( Figure 4E ). In contrast, in the presence of exogenous IL-15, the cells that had undergone most divisions mostly expressed intermediate levels of CD25. Thus, low levels of TCR stimulation gradually expanded a CD4 + T cell + cell recovery on day 5, determined by flow cytometry. Bar graphs represent the mean6SEM. Statistical significance was calculated using student t-test: ns = not significant, ** P,0.01, *** P,0.001. High population was generated. The CD25 Int population only contained CFSE when the CD25 2 CD4 + T cells were CFSElabeled at the start of culture ( Figure 5A ). Conversely, the CD25 High population only contained CFSE when the CD25 + CD4 + T cell subset was CFSE-labeled. Both the CD25 Int and the CD25 High populations were cycling, thus confirming their proliferative capacity ( Figure 5A ). Second, we compared CD25 expression levels in anti-CD3-stimulated cultures of total CD4 + T cells versus CD25-depleted CD4 + T cells and found that initial depletion of CD25 + cells reduced the generation of a CD25 High subset by 2-3-fold ( Figure 5B ). Third, the CD25 High subset of TCR-stimulated CD4 + T cells expresses Foxp3, while the CD25 Int subset is predominantly Foxp3 2 ( Figure 5C ). Finally, CFSE dye dilution showed augmented cell division of CD25 + -depleted CD4 + T cell cultures as compared with total CD4 + T cells ( Figure 5D ). 
cells (d: day). (C) CFSElabeled CD4
+ T cells were stimulated with 0.1 mg/ml anti-CD3 and irradiated TdAC, without or with 3 ng/ml IL-15 for four or five days. Shown are flow cytometry dot plots of CFSE dye dilution versus CD25 expression in the viable CD4 + gate (left, shown percentages were calculated on viable CD4 + T cells) and summarizing bar graph of the CD25 high fraction (left). Statistical significance was calculated using student t-test: * P,0.05, ** P,0.01. Figure 5D ,E). Strikingly, IL-15 addition to Treg-depleted cultures could no longer increase the absolute cell numbers ( Figure 6A 
Discussion
Because of the common usage of IL-2/15Rb and c C receptor components, IL-2 and IL-15 share several biological activities among which the capacity to elicit T cell expansion [1, 71] . In this study, we examined how low doses of exogenous IL-15 enhance proliferative responses to low-level TCR stimulation of T cells. We first found that the growth factor activity of low-dose IL-15 depends on concomitant TCR stimulation, in which case it augments both the strength and the duration of CD4 + T cell responses. This is in line with several reports showing that IL-15 does not support bystander proliferation of CD4 + T cells [72] [73] [74] . Conceivably, innate immune danger signals, such IL-15, serve to boost the protective responses to pathogens that are otherwise faintly stimulatory to CD4 + T cells, while preventing unwanted systemic stimulation of unrelated CD4 + T cells and thus autoimmunity. Yet, high concentrations of IL-15 can increase proliferation of CD4 + T cells independently of polyclonal or Agspecific activation [75] . Such high doses of IL-15 might in fact reflect severe pathological conditions, such as in the case of the highly inflammatory synovium of patients with rheumatoid arthritis [15, 76] , inducing T cell proliferation in the absence of concomitant TCR signals [75] .
Our experiments using neutralizing anti-IL-2 mAbs, and IL-2 This differential dependency on IL-2 could reflect a physiological situation in which innate immune cell-derived IL-15 only supports T cell expansion when IL-2 is produced by TCR-stimulated T cells or by antigen-presenting cells, such as DCs [77] . Later, IL-15 produced by activated monocytes/macrophages within inflamed tissue might support T cell expansion without a strict requirement for TCR signals and IL-2. Mechanistically, this switch from an early, IL-2 dependent growth activity to a late, IL-2 independent growth modus may result from the gradual acquisition by the TCR-stimulated CD4 + T cells of the high-affinity IL-15 receptor. Gene expression analysis indeed showed that activation of CD4 + T cells upregulated the high-affinity receptor subunit IL-15Ra. IL15Ra can, in cis or in trans [78] , combine with IL-2/15Rb and the c c chain to form the heterotrimeric IL-15 receptor, promoting signaling in response to low doses of IL-15.
Interestingly, low-dose anti-CD3 stimulation of murine CD4 [79] that can enhance Treg functionality in vivo [61, 62, 74] . Also, Tregs can scavenge IL-2 thereby depriving Teff of growth factor and causing cell death [80] . Supplementation with IL-2, and as shown here also IL-15, can compensate for this lack of growth factor and explain the reduced suppression and/or increased proliferation in cytokine-supplemented Treg:Teff cocultures. Additionally, cultures that were depleted of nTreg in advance contain ample endogenous IL-2, possibly explaining the lack of effect of IL-15 supplementation in these cultures. As such, our data are in line with a recent report suggesting that IL-15 renders human Teff resistant to suppression by Treg [65] .
This explicit growth promoting effect of IL-15 might be restricted to specific conditions as used in our T cell culture assays, namely low-dose IL-15 and suboptimal TCR occupancy. In the organism, such conditions may occur under certain circumstances, such as low level reactivity to self-antigens or chronic infection. In autoimmunity, IL 15 is detectable at heightened concentrations in the synovial fluid of rheumatoid arthritis patients [15, 16] , the serum of patients with systemic lupus erythematosus [17] or type 1 diabetes [18] , and the affected tissues in autoimmune thyroid disease [19] and celiac disease [20] . In infectious settings, IL-15 derived from innate immune cells can overcome the activation threshold formed by Treg, thereby linking the innate and the adaptive immune system to promote stronger T cell responses to foreign antigens. However, chronic infection can result in prolonged and/or heightened IL-15 expression which in turn, at unusual convergence of events, might link infection to development of autoimmune diseases.
Exploitation of the growth promoting activities of IL-15 supplementation is currently, after encouraging results in preclinical models [21] [22] [23] [24] [25] [26] [27] , validated in clinical trials for tumor therapy and HIV vaccines. Nevertheless, our data showing that IL-15 can help Teff escape the suppression by Treg indicate it is advisable to monitor for autoimmune disease development when using IL-15.
Materials and Methods
Ethics Statement
The study and experimental protocols were performed according to the guidelines of and approved by the Ethical Committee on Laboratory Animal Experimentation of Ghent University. ) mice were purchased from Charles River (Iffa Credo, Italy). IL-2 2/2 C57Bl/ 6 mice were kindly provided by A. Schimpl (University Würzburg, Germany). All mice were housed under specific pathogen-free conditions in temperature-controlled, air-conditioned facilities with 14/10 h light/dark cycles and food and water ad libitum. Spleens were harvested at 7-9 weeks of age. + T cell cultures as described in Materials and Methods, as putative suppressors at indicated ratios, prior to stimulation with 0.1 mg/ml anti-CD3, irradiated TdACs, and indicated cytokines for 3 days. Proliferation was measured via 3 H-thymidine incorporation and the percent suppression was calculated as follows: % suppression = 1006(cpm Responder -cpm Coculture )/cpm Responder . Statistical significance between IL-15-supplemented and nonsupplemented cultures was calculated using two-way ANOVA with Bonferroni posttest: ns: not significant, * P,0.05, ** P,0.01, *** P,0.001 (statistical analysis versus IL-2-supplemented cultures not shown). All experiments were performed at least 3 times with similar results. doi:10.1371/journal.pone.0045299.g006
Reagents Culture medium consisted of RPMI 1640 buffered with 12.5 mM HEPES (Life Technologies, Paisley, Scotland) and supplemented with 10% fetal bovine serum (FBS), 2 mM GlutaMAX-1 (Life Technologies), 100 U/ml penicillin, 100 mg/ ml streptomycin, 1 mM sodium pyruvate, and 5610-5 M bmercaptoethanol. Human IL-15 was purchased from Peprotech (London, UK) and dissolved in PBS. Recombinant murine IL-2 and anti-mouse CD3 mAb (clone 145-2C11) were produced inhouse. Soluble IL-15Ra T1 was used as IL-15 blocking agent, M4 as control protein [70] . FITC-conjugated anti-mouse CD4 (RM4-5), PE-conjugated anti-mouse CD25 (PC61), CyChrome-conjugated anti-mouse CD4 (RM4-5) or CD8 (53-6.7), biotinylated anti-mouse CD4 (RM4-5) or CD25 (PC61), anti-mouse IL2 blocking mAb (JES6-5H4 and S4B6), Fc-block (anti-mouse CD16/CD32, 2.4G2) were all from BD Biosciences (Erembodegem, Belgium). 5-(and-6)-carboxyfluorescein diacetate, succinimidyl ester (CFSE; Invitrogen) was dissolved at 1 mM in DMSO. Flow-Count fluorospheres for quantification of cell numbers were from Beckman Coulter (Paris, France). Protein transport inhibitor Brefeldin A and calcineurin inhibitor cyclosporin A (CsA) were from Sigma.
Purification of T cell Subsets
Bulk splenocytes were processed in PBS, RBC were lysed using ammonium chloride buffer (3 min at room temperature), and cells were passed through a 40-mm cell strainer (BD Biosciences). T celldepleted accessory cells (TdACs) were prepared from splenocytes by depletion of CD90 + (Thy1.2) cells using magnetic microbeads (Miltenyi, Bergisch Glabach, Germany). The column flow-through contained the T cell-depleted accessory cells (TdACs) and routinely showed less than 4% T cell contamination. TdACs were gamma-irradiated (50 Gy) before use. CD25 high and CD25 Int CD4 + T cells were purified from activated CD4 + T cell cultures: First, CD4 + T cells were positively selected using biotinylated anti-CD4 mAb and streptavidinconjugated microbeads according to the manufacturer's instructions, typically yielding .95% CD4 + T cells. Next, cells were stimulated with 0.1 mg/ml anti-CD3 in the presence of irradiated TdACs (1:5). After 3 days, cells were harvested, CD4 cells were enriched using CD4 microbeads (Miltenyi) and simultaneously stained with CyChrome-anti-CD4 and PE-anti-CD25 (2 mg/ml each) prior to flowcytometric sorting (FACSVantage, BD Biosciences). The CD25 high and CD25 intermediate fractions were sorted to .97% purity.
Negative selection of total CD4 + T cells was done using the Mouse CD4
+ T Lymphocyte Enrichment Set -DM (BD Biosciences) according to the manufacturer's instructions. Similarly, this kit was used for the isolation of CD25 2 CD4 + responder T cells, but with supplementation with a biotinylated anti-CD25 mAb (4 mg/ml). 
Cellular Activation and Proliferation Assays
Cell Staining and Absolute Cell Counting
Cells were washed twice with PBS, resuspended at 1610 7 cells/ ml, and incubated with 1mM CFSE for 12 min at 37uC. The labeling reaction was stopped by addition of an equal volume of FCS, and cells were washed twice in medium. For cell counting, CFSE-labeled cells were recovered from micro-well cultures at the indicated time points. Cells were resuspended in FACS buffer (PBS, 0.5% FCS, 2 mM EDTA), stained for mouse CD4 and washed. Next, PI and a known quantity of beads were added, and the cells were acquired by flow cytometry. Absolute cell numbers were calculated using the following formula: Absolute number of CD4 + T cells = (number of beads added/number of beads counted) x number viable CD4 + T cells counted. Flowcytometric data collection from all stained samples was performed on a FACSCalibur using CellQuest software.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism (La Jolla, CA). Statistical significance was calculated by student t-test. Data were considered significantly different at p,0.05. ns = not significant, * P,0.05; ** P,0.01; *** P,0.001.
